<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04089111</url>
  </required_header>
  <id_info>
    <org_study_id>IGHCEAH-ICU-4</org_study_id>
    <nct_id>NCT04089111</nct_id>
  </id_info>
  <brief_title>Closed Loop Ventilation With High Tidal Volumes and Safe Transpulmonary Pressure in COPD (COPD-SAFE)</brief_title>
  <acronym>COPD-SAFE</acronym>
  <official_title>Does Automatically Generated Tidal Volumes With Closed-loop Ventilation Leads to Safe Transpulmonary Pressures in Intubated Chronic Obstructive Pulmonary Disease Patients?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the safety and efficacy of high tidal volumes generated by &quot;Adapted
      Support Ventilation (ASV) mode' in mechanically ventilated severe COPD patients. Every
      patient will be ventilated consecutively with ASV and Volume Control (VC) modes at 2
      different levels of minute volume in 2 sets. ASV mode is expected to be safe measured by
      adequate inspiratory transpulmonary pressures and expected to be as effective as VC mode with
      lower intrinsic positive end expiratory pressure (iPEEP) levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD) may require mechanical
      ventilation. Various mechanical ventilation strategies and modes can be used to manage
      respiratory insufficiency in such patients. High tidal volumes required for mechanical
      ventilation of patients with obstructive pathologies is a well-known fact. Adapted Support
      Ventilation (ASV) is an intelligent closed-loop mechanical ventilation mode which
      automatically adjusts ventilation to lung mechanics. Led by measured lung mechanics, ASV mode
      often generates higher than usual tidal volumes during mechanical ventilation of COPD
      patients, particularly if the minute volume (MV) target is high. Thus, the effects of high
      tidal volumes on inspiratory transpulmonary pressure (Ptp), and whether Ptp stays within safe
      limits during ASV mode is of great interest.

      Patients with acute exacerbation of COPD who required mechanical ventilation will be enrolled
      in the first 24 hours of admission to the intensive care unit. All patients will be deeply
      sedated. An esophageal balloon catheter will be inserted in order to measure transpulmonary
      pressure. 100 % minute volume target will be calculated in advance as 100 ml per ideal body
      weight.

      Patients will be ventilated with two different MV targets in two sets. `Adapted support
      ventilation` and `volume control (VC)` modes will be used consecutively within each set.
      While the target minute volume will be 100 % in the first set, the volume target in the
      second set will be tuned to decrease patients PaCO2 below 45 mmHg. The sequence of
      ventilation mode will be randomized within each set. Ventilation periods will be 30 minutes
      with 15 minutes washout period in between. İf Ptp increase above 20 cmH20 at any ventilation
      mode, the tidal volume will be decreased.

      ASV mode is expected to be safe, assessed by adequate inspiratory transpulmonary pressures,
      and expected to be as effective as VC mode with lower intrinsic positive end expiratory
      pressure (iPEEP) levels.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Patients will be ventilated for two different minute volume targets in two sets. `Adapted support ventilation` and `volume control (VC)` modes will be used consecutively in each set. Every patient will be ventilated 1.1. ASV with minute volume target of % 100; 1.2. VC with same MV target; 2.1 ASV with MV target associated with PaCo2 less than 45 mmHg; 2.2 VC with same MV target. Sequence of ventilation modes wıll be randomized within each group.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Patients will not be aware of the procedure or ventilation modes that will be performed. Outcomes will be analyzed by an independent statistician.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Transpulmonary inspiratory pressure (Ptinsp)</measure>
    <time_frame>30'th minute of each intervention arm</time_frame>
    <description>Ptpinsp will be measured with an inspiratory pause maneuver.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intrinsic Positive End Expiratory Pressure (PEEPi)</measure>
    <time_frame>30'th minute of each intervention arm</time_frame>
    <description>PEEPi will be measured with an expiratory hold maneuver.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Mean arterial pressure</measure>
    <time_frame>30'th minute of each intervention arm</time_frame>
    <description>Mean arterial pressure measured by invasive or non-invasive methods</description>
  </other_outcome>
  <other_outcome>
    <measure>PaO2, FiO2 ratio</measure>
    <time_frame>30'th minute of each intervention arm</time_frame>
    <description>Ratio of arterial partial oxygen pressure to inspired fraction of oxygen</description>
  </other_outcome>
  <other_outcome>
    <measure>Heart rate</measure>
    <time_frame>30'th minute of each intervention arm</time_frame>
    <description>Heart rate measured by ECG</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>1.1. ASV, MV target 100%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be ventilated with ASV mode. Tidal volume, ventilation frequency, inspiratory duration will be automatically adjusted by the mechanical ventilator.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1.2. Volume control, MV target %100</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be ventilated with volume control mode. A tidal volume of 6-8 ml/kg will be used. I:E ratio will be set as 1:3 Ventilation frequency will be adjusted to reach the same volume target calculated in arm1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2.1. ASV, MV target to reach PaCO2&lt; 45 mmHg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be ventilated with ASV mode. Tidal volume, ventilation frequency, inspiratory duration will be automatically adjusted by the mechanical ventilator.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2.2. Volume control, MV target to reach PaCO2&lt; 45 mmHg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be ventilated with volume control mode. A tidal volume of 6-8 ml/kg will be used. I:E ratio will be set as 1:3. Ventilation frequency will be adjusted to reach the target PaCO2 level</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Minute volume target of 100%</intervention_name>
    <description>Patients will be ventilated to reach minute volume target of %100 (100 ml per ideal body weight).</description>
    <arm_group_label>1.1. ASV, MV target 100%</arm_group_label>
    <arm_group_label>1.2. Volume control, MV target %100</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Minute volume target to reach PaCO2 less than 45% (high tidal volume)</intervention_name>
    <description>Patients will be ventilated to reach minute volume target associated with PaCO2 less than 45%.</description>
    <arm_group_label>2.1. ASV, MV target to reach PaCO2&lt; 45 mmHg</arm_group_label>
    <arm_group_label>2.2. Volume control, MV target to reach PaCO2&lt; 45 mmHg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute exacerbation of Chronic Obstructive Lung Disease

          -  Being intubated for less than 24 hours

          -  Not being planned to be extubated in 24 hours

          -  Expiratory time constant (RCexp) more than &gt; 2.0 s

        Exclusion Criteria:

          -  Restrictive lung pathologies

          -  Impaired hemodynamic status

          -  Esophageal pathologies

          -  Bronchopleural fistula
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sami C Kirakli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr. Suat Seren Chest Diseases and Surgery Educatin and Resarch Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sami C Kirakli, MD</last_name>
    <phone>+905052352024</phone>
    <email>samicenk.kirakli@sbu.edu.tr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Burcu Acar Cinleti, MD</last_name>
    <phone>+905075022780</phone>
    <email>burcu_acar911@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Izmir Dr. Suat Seren Chest Diseases and Surgery Education and Research Hospital, Intensive Care Unit</name>
      <address>
        <city>Izmir</city>
        <state>Yenisehir</state>
        <zip>35550</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Talmor D, Sarge T, Malhotra A, O'Donnell CR, Ritz R, Lisbon A, Novack V, Loring SH. Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med. 2008 Nov 13;359(20):2095-104. doi: 10.1056/NEJMoa0708638. Epub 2008 Nov 11.</citation>
    <PMID>19001507</PMID>
  </reference>
  <reference>
    <citation>Grieco DL, Chen L, Brochard L. Transpulmonary pressure: importance and limits. Ann Transl Med. 2017 Jul;5(14):285. doi: 10.21037/atm.2017.07.22. Review.</citation>
    <PMID>28828360</PMID>
  </reference>
  <reference>
    <citation>Mauri T, Yoshida T, Bellani G, Goligher EC, Carteaux G, Rittayamai N, Mojoli F, Chiumello D, Piquilloud L, Grasso S, Jubran A, Laghi F, Magder S, Pesenti A, Loring S, Gattinoni L, Talmor D, Blanch L, Amato M, Chen L, Brochard L, Mancebo J; PLeUral pressure working Group (PLUG—Acute Respiratory Failure section of the European Society of Intensive Care Medicine). Esophageal and transpulmonary pressure in the clinical setting: meaning, usefulness and perspectives. Intensive Care Med. 2016 Sep;42(9):1360-73. doi: 10.1007/s00134-016-4400-x. Epub 2016 Jun 22. Review.</citation>
    <PMID>27334266</PMID>
  </reference>
  <reference>
    <citation>Akoumianaki E, Maggiore SM, Valenza F, Bellani G, Jubran A, Loring SH, Pelosi P, Talmor D, Grasso S, Chiumello D, Guérin C, Patroniti N, Ranieri VM, Gattinoni L, Nava S, Terragni PP, Pesenti A, Tobin M, Mancebo J, Brochard L; PLUG Working Group (Acute Respiratory Failure Section of the European Society of Intensive Care Medicine). The application of esophageal pressure measurement in patients with respiratory failure. Am J Respir Crit Care Med. 2014 Mar 1;189(5):520-31. doi: 10.1164/rccm.201312-2193CI. Review.</citation>
    <PMID>24467647</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>September 11, 2019</study_first_submitted>
  <study_first_submitted_qc>September 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2019</study_first_posted>
  <last_update_submitted>February 12, 2020</last_update_submitted>
  <last_update_submitted_qc>February 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Cenk Kirakli, M.D.</investigator_full_name>
    <investigator_title>Associate Professor Cenk Kirakli. M.D.</investigator_title>
  </responsible_party>
  <keyword>Mechanical ventilation</keyword>
  <keyword>Adaptive Support Ventilation</keyword>
  <keyword>Transpulmonary pressure</keyword>
  <keyword>Intrinsic PEEP</keyword>
  <keyword>Safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

